1. Home
  2. BNTC vs GDEV Comparison

BNTC vs GDEV Comparison

Compare BNTC & GDEV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Benitec Biopharma Inc.

BNTC

Benitec Biopharma Inc.

HOLD

Current Price

$9.59

Market Cap

396.3M

Sector

Health Care

ML Signal

HOLD

Logo GDEV Inc.

GDEV

GDEV Inc.

HOLD

Current Price

$10.90

Market Cap

197.3M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
BNTC
GDEV
Founded
1995
2009
Country
United States
Cyprus
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
EDP Services
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
396.3M
197.3M
IPO Year
2020
2021

Fundamental Metrics

Financial Performance
Metric
BNTC
GDEV
Price
$9.59
$10.90
Analyst Decision
Strong Buy
Analyst Count
3
0
Target Price
★ $27.67
N/A
AVG Volume (30 Days)
★ 124.1K
904.0
Earning Date
05-14-2026
05-15-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 6.67
N/A
EPS
N/A
★ N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$8.56
Revenue Next Year
N/A
$8.05
P/E Ratio
★ N/A
$5.19
Revenue Growth
N/A
N/A
52 Week Low
$9.26
$10.00
52 Week High
$16.76
$42.20

Technical Indicators

Market Signals
Indicator
BNTC
GDEV
Relative Strength Index (RSI) 27.48 42.35
Support Level N/A $10.65
Resistance Level $13.49 $12.00
Average True Range (ATR) 0.74 0.39
MACD -0.24 -0.02
Stochastic Oscillator 12.42 15.89

Price Performance

Historical Comparison
BNTC
GDEV

About BNTC Benitec Biopharma Inc.

Benitec Biopharma Inc is a clinical-stage biotechnology company focused on advancing novel genetic medicines. Its technology could provide a one-shot cure for a wide range of diseases that require strict, ongoing treatment regimens or have no effective treatment or only palliative care options. The Company is developing a silence-and-replace-based therapeutic (BB-301) for the treatment of Oculopharyngeal Muscular Dystrophy (OPMD), a chronic, life-threatening genetic disorder. The company has a single operating segment, which is the business of discovery and development of therapeutic agents for the treatment of genetic disorders.

About GDEV GDEV Inc.

GDEV Inc is a gaming and entertainment holding company that oversees a portfolio of studios focused on developing and publishing live-service games across a range of platforms and genres. Its portfolio includes studios specializing in mobile, browser, and PC games, as well as captivating IPs spanning various genres.

Share on Social Networks: